Dynamic risk assessment in patients with differentiated thyroid cancer

被引:0
作者
Abelleira, Erika [1 ]
Jerkovich, Fernando [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose San Martin UBA, Div Endocrinol, Cordoba 2351,5th floor, RA-1120 Cordoba, Buenos Aires, Argentina
关键词
Dynamic risk assessment; Risk of recurrence; Differentiated thyroid cancer; Thyroid cancer; CLINICALLY SIGNIFICANT DISEASE; RADIOIODINE REMNANT ABLATION; FALSE-POSITIVE ABNORMALITIES; RADIOACTIVE IODINE THERAPY; SERIAL NECK ULTRASOUND; QUALITY-OF-LIFE; ACTIVE SURVEILLANCE; PAPILLARY MICROCARCINOMA; STRATIFICATION SYSTEM; MANAGEMENT GUIDELINES;
D O I
10.1007/s11154-023-09857-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current approach for patients with differentiated thyroid carcinoma should be individualized according to the risk of recurrence, and this stratification could be used to identify the risk of persistent/recurrent disease in three scenarios: preoperatively, immediately postoperatively, and during long-term follow-up. The initial risk of recurrence will tailor the management of the patient in the preoperative and immediate postoperative settings, while the dynamic risk, which considers the responses to treatment, could guide the decision-making process for remnant ablation and long-term management.This review provides a summary of the existing information regarding the dynamic risk of recurrence and recommended management for patients with differentiated thyroid cancer. The application of this approach is essential to avoid unnecessary treatments for most patients who will have a favorable prognosis. On the other hand, it allows specific therapeutic interventions for those patients at high risk of recurrence. In the future, analysis of tumor biology and prospective studies will surely improve the accuracy of recurrence risk prediction.
引用
收藏
页码:79 / 93
页数:15
相关论文
共 50 条
  • [41] Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population
    Singh, Shashank Shekhar
    Mittal, Bhagwant Rai
    Sood, Ashwani
    Bhattacharya, Anish
    Kumar, Ganesh
    Shekhawat, Amit Singh
    Singh, Harpreet
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2022, 21 (02) : 127 - 136
  • [42] 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
    Haugen, Bryan R.
    Alexander, Erik K.
    Bible, Keith C.
    Doherty, Gerard M.
    Mandel, Susan J.
    Nikiforov, Yuri E.
    Pacini, Furio
    Randolph, Gregory W.
    Sawka, Anna M.
    Schlumberger, Martin
    Schuff, Kathryn G.
    Sherman, Steven I.
    Sosa, Julie Ann
    Steward, David L.
    Tuttle, R. Michael
    Wartofsky, Leonard
    THYROID, 2016, 26 (01) : 1 - 133
  • [43] Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer
    Mukhtar, Noha
    Aljamei, Hadeel
    Aljomaiah, Abeer
    Moria, Yosra
    Alzahrani, Ali S.
    EUROPEAN THYROID JOURNAL, 2021, 10 (03) : 198 - 207
  • [44] Editorial: Improving quality of life in patients with differentiated thyroid cancer
    Khafif, Avi Hefetz
    Cohen, Oded
    Dionigi, Gianlorenzo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer
    Fernanda Bueno
    María Gabriela García Falcone
    Mirna Angela Peñaloza
    Erika Abelleira
    Fabián Pitoia
    Endocrine, 2020, 67 : 387 - 396
  • [46] Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer
    Bueno, Fernanda
    Garcia Falcone, Maria Gabriela
    Angela Penaloza, Mirna
    Abelleira, Erika
    Pitoia, Fabian
    ENDOCRINE, 2020, 67 (02) : 387 - 396
  • [47] Thyroglobulin in differentiated thyroid cancer
    Evans, Carol
    Tennant, Sarah
    Perros, Petros
    CLINICA CHIMICA ACTA, 2015, 444 : 310 - 317
  • [48] Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma
    Tarasova, V. D.
    Tuttle, R. M.
    CLINICAL ONCOLOGY, 2017, 29 (05) : 290 - 297
  • [49] Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer
    Klain, Michele
    Zampella, Emilia
    Manganelli, Mariarosaria
    Gaudieri, Valeria
    Nappi, Carmela
    D'Antonio, Adriana
    Piscopo, Leandra
    Volpe, Fabio
    Pace, Leonardo
    Schlumberger, Martin
    Cuocolo, Alberto
    ENDOCRINE, 2021, 71 (02) : 378 - 384
  • [50] Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe
    Michel Henry-Amar
    Jean-Jacques Michels
    Jean-Pierre Rame
    Pascaline Berthet
    Emmanuel Babin
    Philippe Icard
    Guy Samama
    Françoise Galateau-Sallé
    Jacques Mahoudeau
    Stéphane Bardet
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 685 - 691